<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68225-121-00
</NDCCode>
<PackageDescription>
51 VIAL in 1 BOX (68225-121-00) > 40 mL in 1 VIAL
</PackageDescription>
<NDC11Code>
68225-0121-00
</NDC11Code>
<ProductNDC>
68225-121
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Oritavancin Diphosphate
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20210323
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Patheon Italia S.p.A.
</LabelerName>
<SubstanceName>
ORITAVANCIN DIPHOSPHATE
</SubstanceName>
<StrengthNumber>
1200
</StrengthNumber>
<StrengthUnit>
mg/40mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2021-03-27
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20221231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
23-MAR-21
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>